Marita Zuraitis
Known title: President & CEOCIK: 0001198960
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Citizens Financial Reports Q3 Earnings Beat and Dividend Increase. Citizens Financial Group posted third‑quarter results that topped analysts’ expectations, driven by growth in net interest income. The company also raised its quarterly dividend. Management highlighted the earnings beat during the call and noted the bank’s positioning within the regional banking sector. The results arrived as the stock traded near a key support level.
Transaction History
| HMN | ▼ Sell | Open Market | 100 | $5K | 10/6/2026 | View on chart |
| HMN | ▼ Sell | Open Market | 7,500 | $382K | 9/1/2026 | View on chart |
| CFG | ▲ Buy | Grant | 269 | $0 | 8/13/2026 | View on chart |
| HMN | ▼ Sell | Open Market | 7,500 | $390K | 8/3/2026 | View on chart |
| HMN | ▼ Sell | Open Market | 7,500 | $395K | 7/1/2026 | View on chart |
| HMN | ▼ Sell | Tax Withholding | 65,465 | $3.3M | 6/24/2026 | View on chart |
| HMN | ▼ Sell | Tax Withholding | 63,678 | $3.2M | 6/24/2026 | View on chart |
| HMN | ▲ Buy | Option Exercise | 71,532 | $3.1M | 6/24/2026 | View on chart |
| HMN | ▲ Buy | Option Exercise | 70,424 | $3.0M | 6/24/2026 | View on chart |
| HMN | ▼ Sell | Open Market | 7,500 | $347K | 6/2/2026 | View on chart |
| HMN | ▼ Sell | Open Market | 14 | $646 | 5/19/2026 | View on chart |
| CFG | ▲ Buy | Grant | 323 | $0 | 5/14/2026 | View on chart |
| HMN | ▼ Sell | Open Market | 2 | $92 | 5/6/2026 | View on chart |
| HMN | ▼ Sell | Open Market | 403 | $19K | 5/5/2026 | View on chart |
| HMN | ▼ Sell | Open Market | 266 | $12K | 5/4/2026 | View on chart |
| HMN | ▼ Sell | Open Market | 6,815 | $315K | 5/1/2026 | View on chart |
| CFG | ▲ Buy | Grant | 2,608 | $0 | 4/23/2026 | View on chart |
| HMN | ▼ Sell | Open Market | 7,500 | $346K | 4/23/2026 | View on chart |
| HMN | ▲ Buy | Grant | 21,957 | $0 | 3/4/2026 | View on chart |
| HMN | ▲ Buy | Grant | 63,056 | $0 | 3/4/2026 | View on chart |
| CFG | ▲ Buy | Grant | 283 | $0 | 2/18/2026 | View on chart |
| HMN | ▼ Sell | Open Market | 5,000 | $226K | 1/2/2026 | View on chart |
| HMN | ▼ Sell | Open Market | 5,000 | $227K | 12/1/2025 | View on chart |
| CFG | ▲ Buy | Grant | 347 | $0 | 11/12/2025 | View on chart |
| HMN | ▼ Sell | Open Market | 5,000 | $221K | 11/3/2025 | View on chart |
| HMN | ▼ Sell | Open Market | 5,000 | $224K | 10/1/2025 | View on chart |
| HMN | ▼ Sell | Open Market | 5,000 | $229K | 9/2/2025 | View on chart |
| CFG | ▲ Buy | Grant | 336 | $0 | 8/14/2025 | View on chart |
| HMN | ▼ Sell | Open Market | 5,000 | $211K | 8/1/2025 | View on chart |
| HMN | ▼ Sell | Open Market | 5,000 | $214K | 7/1/2025 | View on chart |
| HMN | ▼ Sell | Open Market | 5,000 | $216K | 6/2/2025 | View on chart |
| CFG | ▲ Buy | Grant | 394 | $0 | 5/14/2025 | View on chart |
| HMN | ▼ Sell | Open Market | 5,000 | $207K | 5/1/2025 | View on chart |
| CFG | ▲ Buy | Grant | 4,273 | $0 | 4/24/2025 | View on chart |
| HMN | ▼ Sell | Open Market | 5,000 | $215K | 4/1/2025 | View on chart |
| HMN | ▲ Buy | Grant | 19,977 | $0 | 3/5/2025 | View on chart |
| HMN | ▲ Buy | Grant | 31,354 | $0 | 3/5/2025 | View on chart |
| CFG | ▲ Buy | Grant | 312 | $0 | 2/14/2025 | View on chart |
| HMN | ▼ Sell | Open Market | 4,000 | $149K | 2/3/2025 | View on chart |
| HMN | ▼ Sell | Open Market | 4,000 | $158K | 1/2/2025 | View on chart |
| HMN | ▼ Sell | Open Market | 4,000 | $168K | 12/2/2024 | View on chart |
| CFG | ▲ Buy | Grant | 309 | $0 | 11/13/2024 | View on chart |
| HMN | ▲ Buy | Option Exercise | 10,346 | $321K | 11/11/2024 | View on chart |
| HMN | ▲ Buy | Option Exercise | 10,346 | $321K | 11/11/2024 | View on chart |
| HMN | ▼ Sell | Open Market | 8,821 | $371K | 11/11/2024 | View on chart |
| HMN | ▼ Sell | Open Market | 8,808 | $373K | 11/11/2024 | View on chart |
| HMN | ▲ Buy | Option Exercise | 20,000 | $620K | 11/8/2024 | View on chart |
| HMN | ▼ Sell | Open Market | 17,213 | $707K | 11/8/2024 | View on chart |
| HMN | ▲ Buy | Option Exercise | 20,000 | $620K | 11/8/2024 | View on chart |
| HMN | ▼ Sell | Open Market | 17,285 | $706K | 11/8/2024 | View on chart |
| HMN | ▲ Buy | Option Exercise | 2,418 | $75K | 11/7/2024 | View on chart |
| HMN | ▼ Sell | Tax Withholding | 1,785 | $75K | 11/7/2024 | View on chart |
| HMN | ▲ Buy | Option Exercise | 806 | $25K | 11/7/2024 | View on chart |
| HMN | ▼ Sell | Open Market | 691 | $29K | 11/7/2024 | View on chart |
| HMN | ▲ Buy | Option Exercise | 20,000 | $620K | 11/7/2024 | View on chart |
| HMN | ▼ Sell | Open Market | 17,107 | $714K | 11/7/2024 | View on chart |
| HMN | ▼ Sell | Open Market | 4,000 | $149K | 11/1/2024 | View on chart |
| HMN | ▲ Buy | Option Exercise | 1,828 | $59K | 10/18/2024 | View on chart |
| HMN | ▲ Buy | Option Exercise | 106 | $3K | 10/18/2024 | View on chart |
| HMN | ▼ Sell | Open Market | 16,000 | $592K | 10/17/2024 | View on chart |
| HMN | ▲ Buy | Option Exercise | 24,677 | $798K | 10/17/2024 | View on chart |
| HMN | ▼ Sell | Open Market | 24,677 | $915K | 10/17/2024 | View on chart |
| HMN | ▲ Buy | Option Exercise | 1,440 | $47K | 10/17/2024 | View on chart |
| HMN | ▼ Sell | Open Market | 1,440 | $53K | 10/17/2024 | View on chart |
| CFG | ▲ Buy | Grant | 353 | $0 | 8/14/2024 | View on chart |
| CFG | ▲ Buy | Grant | 381 | $0 | 5/15/2024 | View on chart |
| CFG | ▲ Buy | Grant | 4,428 | $0 | 4/25/2024 | View on chart |
| HMN | ▼ Sell | Open Market | 1,250 | $46K | 3/28/2024 | View on chart |
| HMN | ▲ Buy | Option Exercise | 1,545 | $50K | 3/7/2024 | View on chart |
| HMN | ▼ Sell | Tax Withholding | 1,425 | $50K | 3/7/2024 | View on chart |
| HMN | ▲ Buy | Grant | 23,511 | $0 | 3/6/2024 | View on chart |
| HMN | ▲ Buy | Grant | 26,763 | $0 | 3/6/2024 | View on chart |
| CFG | ▲ Buy | Grant | 383 | $0 | 2/14/2024 | View on chart |
| HMN | ▼ Sell | Open Market | 2,700 | $100K | 2/8/2024 | View on chart |
| HMN | ▲ Buy | Option Exercise | 314 | $9K | 1/30/2024 | View on chart |
| HMN | ▲ Buy | Option Exercise | 3,618 | $104K | 1/30/2024 | View on chart |
| HMN | ▼ Sell | Open Market | 21,600 | $800K | 1/29/2024 | View on chart |
| HMN | ▲ Buy | Option Exercise | 26,216 | $757K | 1/29/2024 | View on chart |
| HMN | ▼ Sell | Open Market | 26,216 | $974K | 1/29/2024 | View on chart |
| HMN | ▲ Buy | Option Exercise | 2,282 | $66K | 1/29/2024 | View on chart |
| HMN | ▼ Sell | Open Market | 2,282 | $85K | 1/29/2024 | View on chart |
| CFG | ▲ Buy | Grant | 433 | $0 | 11/15/2023 | View on chart |
| CFG | ▲ Buy | Grant | 414 | $0 | 8/16/2023 | View on chart |
| CFG | ▲ Buy | Grant | 434 | $0 | 5/17/2023 | View on chart |
| CFG | ▲ Buy | Grant | 4,818 | $0 | 4/27/2023 | View on chart |
| HMN | ▲ Buy | Option Exercise | 866 | $25K | 3/31/2023 | View on chart |
| HMN | ▼ Sell | Tax Withholding | 752 | $25K | 3/31/2023 | View on chart |
| HMN | ▲ Buy | Grant | 21,390 | $0 | 3/8/2023 | View on chart |
| HMN | ▲ Buy | Grant | 31,369 | $0 | 3/8/2023 | View on chart |
| CFG | ▲ Buy | Grant | 216 | $0 | 2/14/2023 | View on chart |
| CFG | ▲ Buy | Grant | 233 | $0 | 11/16/2022 | View on chart |
| CFG | ▲ Buy | Grant | 228 | $0 | 8/16/2022 | View on chart |
| CFG | ▲ Buy | Grant | 214 | $0 | 5/17/2022 | View on chart |
| CFG | ▲ Buy | Grant | 3,349 | $0 | 4/28/2022 | View on chart |
| HMN | ▲ Buy | Grant | 14,499 | $0 | 3/9/2022 | View on chart |
| HMN | ▲ Buy | Grant | 31,187 | $0 | 3/9/2022 | View on chart |
| CFG | ▲ Buy | Grant | 130 | $0 | 2/11/2022 | View on chart |
| CFG | ▲ Buy | Grant | 142 | $0 | 11/12/2021 | View on chart |
| HMN | ▼ Sell | Open Market | 3,333 | $133K | 9/24/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 12, 2026
Horace Mann Q2 Earnings Call and Insurance Sector Outlook
Horace Mann Educators released its Q2 2026 earnings conference call transcript, providing details on recent performance. The company is also featured in industry outlooks and lists of multiline insurance stocks, highlighting its role in the broader sector. While peer Aflac announced new AI tools, Horace Mann’s news focuses on its own financial results and market position within the insurance industry.
Horace Mann Q2 Earnings Call and Insurance Sector Outlook. Horace Mann Educators released its Q2 2026 earnings conference call transcript, providing details on recent performance. The company is also featured in industry outlooks and lists of multiline insurance stocks, highlighting its role in the broader sector. While peer Aflac announced new AI tools, Horace Mann’s news focuses on its own financial results and market position within the insurance industry.